Home › Funds › Sofinnova Investments, Inc. › BIOA

Sofinnova Investments, Inc. position in BIOA

BIOAGE LABS INC · Health Care

Sofinnova Investments, Inc. reported holding 2,293,788 shares of BIOA (BIOAGE LABS INC) in its Q2 2026 13F filing — a position valued at US$56.2M, representing 3.00% of its reported portfolio and ranking #8 among its reported holdings. Sofinnova Investments, Inc. has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)2.29M sh
Reported value held$56.22M
Portfolio Weight3.00%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s BIOA position evolved

Sofinnova Investments, Inc. first disclosed a stake in BIOA in Q3 2024 at 2,304,901 shares (US$47.9M). The position peaked in Q2 2026 at 2,293,788 shares, worth US$56.2M. Across 8 filings, Sofinnova Investments, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,293,788 shares valued at US$56.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.30M $47.94M New
Q4 2024 2.30M $13.35M Hold
Q1 2025 2.30M $8.67M Hold
Q2 2025 2.30M $9.52M Hold
Q3 2025 2.29M $13.49M Hold
Q4 2025 2.29M $30.35M Hold
Q1 2026 2.29M $40.12M Hold
Q2 2026 2.29M $56.22M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIOA and 13F data

BIOA (BIOAGE LABS INC) is a Health Care company. 78 other funds we track also report a position in BIOA — the largest reported positions include a16z Capital Management, L.L.C. (US$79.2M), Cormorant Asset Management, LP (US$58.6M), Octagon Capital Advisors LP (US$42.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIOA

All BIOA fund holders →

FAQ

How long has Sofinnova Investments, Inc. held BIOA?

Sofinnova Investments, Inc. has disclosed BIOA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Sofinnova Investments, Inc.'s current position in BIOA?

As of Q2 2026, Sofinnova Investments, Inc. holds 2.29M shares of BIOA (BIOAGE LABS INC), valued at $56.22M, representing 3.00% of its reported portfolio and ranking #8.

Has Sofinnova Investments, Inc. been buying or selling BIOA?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. held unchanged its position in BIOA. The position peaked in Q2 2026 at 2.29M shares.

Which other funds hold BIOA?

Other major institutional holders of BIOA include a16z Capital Management, L.L.C., Cormorant Asset Management, LP, Octagon Capital Advisors LP, among 78 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.